We previously reported that the treatment with the classical CAXII inhibitor acetazolamide (AZA), as well as CAXII silencing, lowered the pHi of doxorubicin-resistant colon cancer cells and reduced Pgp activity [16]. Here, CA12 is linked to malignant colon neoplasm.